Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Basic): 2017-2025

Historic EPS (Basic) for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Basic) rose 22.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 86.62%. This contributed to the annual value of -$0.01 for FY2024, which is 125.00% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' EPS (Basic) is $0.11, which was up 210.00% from -$0.10 recorded in Q2 2025.
  • Organogenesis Holdings' 5-year EPS (Basic) high stood at $0.39 for Q4 2021, and its period low was -$0.17 during Q1 2025.
  • For the 3-year period, Organogenesis Holdings' EPS (Basic) averaged around -$0.01, with its median value being -$0.00 (2023).
  • Per our database at Business Quant, Organogenesis Holdings' EPS (Basic) spiked by 1,117.56% in 2023 and then crashed by 750.00% in 2025.
  • Over the past 5 years, Organogenesis Holdings' EPS (Basic) (Quarterly) stood at $0.39 in 2021, then plummeted by 84.62% to $0.06 in 2022, then plummeted by 107.17% to -$0.00 in 2023, then spiked by 1,029.87% to $0.04 in 2024, then increased by 22.22% to $0.11 in 2025.
  • Its last three reported values are $0.11 in Q3 2025, -$0.10 for Q2 2025, and -$0.17 during Q1 2025.